Created at	Source	Raw Value	Validated value
April 11, 2024, midnight	usa	Geometric Mean (GM) of the Serum Antibody (Ab) Level against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration at Day 57;GM of the Serum Ab Level against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration at Day 29;GM of the Serum Ab Level against Omicron XBB.1.5 after mRNA-1273.815 Administration;Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);Seroresponse Rate (SRR) against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration	Geometric Mean (GM) of the Serum Antibody (Ab) Level against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration at Day 57;GM of the Serum Ab Level against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration at Day 29;GM of the Serum Ab Level against Omicron XBB.1.5 after mRNA-1273.815 Administration;Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);Seroresponse Rate (SRR) against Omicron BA.1 and Ancestral SARS-CoV-2 after mRNA-1273.214 Administration
Feb. 2, 2023, 4 p.m.	usa	Geometric Mean (GM) of the Serum Antibody (Ab) Level Against SARS-CoV-2 (Omicron BA.1 and Ancestral SARS-CoV-2);GM of the Serum Ab Level Against SARS-CoV-2 (Omicron BA.1 and Ancestral SARS-CoV-2);Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);SRR of Vaccine Recipients of SARS-CoV-2 VOC (Omicron BA.1 and Ancestral SARS-CoV-2)	Geometric Mean (GM) of the Serum Antibody (Ab) Level Against SARS-CoV-2 (Omicron BA.1 and Ancestral SARS-CoV-2);GM of the Serum Ab Level Against SARS-CoV-2 (Omicron BA.1 and Ancestral SARS-CoV-2);Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);SRR of Vaccine Recipients of SARS-CoV-2 VOC (Omicron BA.1 and Ancestral SARS-CoV-2)
June 30, 2022, 10:30 p.m.	usa	Geometric Mean (GM) of the Serum Antibody (Ab) Level (Omicron);GM of the Serum Ab Level Post BD (Omicron);Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);Seroresponse Rate (SRR) of Vaccine Recipients (Omicron);SRR of Vaccine Recipients Post BD (Omicron)	Geometric Mean (GM) of the Serum Antibody (Ab) Level (Omicron);GM of the Serum Ab Level Post BD (Omicron);Number of Participants with Adverse Events of Special Interest (AESI);Number of Participants with AEs Leading to Withdrawal;Number of Participants with Medically-Attended AEs (MAAEs);Number of Participants with Serious AEs (SAEs);Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs);Number of Participants with Unsolicited Adverse Events (AEs);Seroresponse Rate (SRR) of Vaccine Recipients (Omicron);SRR of Vaccine Recipients Post BD (Omicron)